The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global bone growth stimulator market reached a value of US$ 1.91 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.6 Billion by 2027, exhibiting a CAGR of 5.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A bone growth stimulator is a medical device used to boost the healing process of bones after a spinal fusion surgery or fracture. It relies on ultrasonic or pulsed electromagnetic waves to assist the body in tissue repairing and cell creation while increasing bone density. It helps treat nonunion fractures that occur due to the lack of stability, blood flow, and infections, particularly after surgery. In addition, it offers several advantages, including a painless healing process, low complication rates compared to other invasive methods, and increasing patient compliance. As a result, it finds extensive applications in hospitals, clinics, and home care centers across the globe.
At present, there is a rise in the demand for minimally invasive (MI) procedures due to fewer operative complications, shorter hospitalization, less pain, reduced postoperative care, quicker recovery, smaller and more cosmetic incisions, and lower risk of infection. This, along with the growing geriatric population around the world, represents one of the key factors driving the market. Moreover, the increasing sports-related orthopedic injuries among individuals due to poor training practices, improper equipment, insufficient warm-up and stretching, and lack of conditioning are propelling the growth of the market. In addition, governments of several countries are extensively investing in medical equipment and devices. This, coupled with the burgeoning healthcare industry across the globe, is offering lucrative growth opportunities to industry players. Besides this, the growing awareness among physicians, surgeons, and patients about the benefits of bone growth stimulators for spinal fusion and bone healing is positively influencing the market. Additionally, the rising prevalence of arthritis, diabetes, and other medical conditions, such as obesity, vascular disease, and renal disorders, is strengthening the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global bone growth stimulator market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation) and Zimmer Biomet
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation) and Zimmer Biomet|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at